Newsroom: Top News Top News | All News Allarity Therapeutics Reports First Quarter 2026 Results and Continued Stenoparib Development in Multiple Cancers May 15, 2026 Read More Allarity Therapeutics CEO to Present at Precision Medicine Forum Europe 2026 in Stockholm May 08, 2026 Read More Allarity Therapeutics Advances Stenoparib Toward Pivotal Development with Phase 3 Manufacturing Campaign May 05, 2026 Read More